Metraipolis › archive › dc_e0cfcc54c87e

First-line CDK4/6 inhibitor treatment of HR-positive, HER2-negative metastatic breast cancer: real-world data from Ho Chi Minh City Oncology Hospital, Vietnam — Europe PMC PMID:42780725

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42780725
DOI
10.3389/fonc.2026.1871703
License (as archived)
solo-consultazione
Archived
2026-10-15T23:25:33.338Z
SHA-256 of the archived text
236ec15cf0942d32c2095dc5c6fa8cf34699619a0d9d5827b5f85edf7dcabcb7
Stable URL of this page
https://metraipolis.com/documento/dc_e0cfcc54c87e

How to cite

First-line CDK4/6 inhibitor treatment of HR-positive, HER2-negative metastatic breast cancer: real-world data from Ho Chi Minh City Oncology Hospital, Vietnam — Europe PMC PMID:42780725 — Europe PMC (en), https://europepmc.org/article/MED/42780725 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e0cfcc54c87e (Metraipolis archive dc_e0cfcc54c87e, sha256 236ec15cf0942d32c2095dc5c6fa8cf34699619a0d9d5827b5f85edf7dcabcb7)
BibTeX
@misc{dce0cfcc54c87e,
  title = {First-line CDK4/6 inhibitor treatment of HR-positive, HER2-negative metastatic breast cancer: real-world data from Ho Chi Minh City Oncology Hospital, Vietnam — Europe PMC PMID:42780725},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42780725},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e0cfcc54c87e; sha256 236ec15cf0942d32c2095dc5c6fa8cf34699619a0d9d5827b5f85edf7dcabcb7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42780725. Agents can read the archived copy with the MCP tool read_document.